Can metabolic activity predict response in early-stage lung cancer treated with stereotactic body radiation therapy?

Author： Horne Zachary D Clump David A Heron Dwight E

ISSN： 1758-1966

Source： Lung Cancer Management, Vol.2, Iss.3, 2013-06, pp. : 165-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience

By Hiraoka Masahiro Nagata Yasushi

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 352-355

Springer Publishing Company

Access to resources Recommend Favorite

Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates

By Jeppesen Stefan S. Schytte Tine Jensen Henrik R. Brink Carsten Hansen Olfred

Acta Oncologica, Vol. 52, Iss. 7, 2013-10 ,pp. : 1552-1558

Informa Healthcare

Access to resources Recommend Favorite

Stereotactic Body Radiation Therapy for Stage I Non-small-cell Lung Cancer: A Historical Overview of Clinical Studies

By Onishi Hiroshi Araki Tsutomu

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 345-350

Oxford University Press

Access to resources Recommend Favorite

Developments in stereotactic ablative radiotherapy for the treatment of early-stage lung cancer

By Westover Kenneth D Timmerman Robert

Lung Cancer Management, Vol. 2, Iss. 2, 2013-04 ,pp. : 129-139

Future Medicine

Access to resources Recommend Favorite

Stereotactic Body Radiation Therapy (SBRT) for lung metastases

By Okunieff Paul Petersen Anncatrine Philip Abraham Milano Michael Katz Alan Boros Laszlo Schell Michael

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 808-817

Informa Healthcare

Access to resources Recommend Favorite